Seeing these case studies reminds me why I've pumped so much money into this company.
Read the conclusion, about this method being non-inferior in result to standard procedure AND more ch safer, and cheaper, despite India being in the grips of a terrible wave of covid.
Thanks for the study.
India has a huge population of people, and they're a massive market for us. When our product allows for cheaper results with fewer complications we are th obvious choice.
For comparison, things like expensive stem cell therapies would be slow to be taken up by third world countries. But cheaper alternatives to standard plastics procedures?
What do y'all think.
Very exciting times everyone.
More great work, page-2
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.52 |
Change
-0.050(1.95%) |
Mkt cap ! $1.739B | |||
| Open | High | Low | Value | Volume |
| $2.60 | $2.60 | $2.51 | $2.348M | 921.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 22274 | $2.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.53 | 10711 | 1 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |